Clinical Trials Logo

Dermal Filler clinical trials

View clinical trials related to Dermal Filler.

Filter by:
  • Completed  
  • Page 1

NCT ID: NCT05822778 Completed - Dermal Filler Clinical Trials

Formaderm (Hyaluronic Acid) for Facial Soft Tissue Augmentation

Start date: February 13, 2014
Phase: N/A
Study type: Interventional

The goal of this clinical trial is to evaluate the safety and efficacy of Formaderm (hyaluronic acid) dermal filler injection for soft tissue augmentation. The main questions it aims to answer are: - The differences of Wrinkle Severity Rating Scale (WSRS) after the injection. - The differences of Global Aesthetic Improvement Scale (GAIS) after the injection. - The subjective satisfaction of treatment. - Safety Indicators of which incidences on the day of the injection or after the injection. Participants will be self-controlled and randomized for same period - received both trial product and control product at the same time. - re-visited on week 2, 4, 12, 24, 36, and 52 after injection. Researchers will compare if the test product is non-inferiority to Q-Med Restylane.

NCT ID: NCT05294562 Completed - Hyaluronic Acid Clinical Trials

China Post-Market Clinical Follow-up of FACILLE®

Start date: December 14, 2016
Phase:
Study type: Observational

The results showed that subjects tolerated the Sodium Hyaluronate Gel for Injection (FACILLE®) well, with no systemic AEs, SAEs, and unanticipated AEs and associated with high satisfaction and self-evaluated effectiveness. Nearly half of the subjects maintained correction for 12 months and were satisfied with the product 3 years after the first injection.

NCT ID: NCT04622085 Completed - Lidocaine Clinical Trials

The Evaluation of the Safety and Effectiveness of ANIMERS Chiara LA and JUVÉDERM VOLUMA® for Aging Mid-Face

Start date: April 6, 2021
Phase: N/A
Study type: Interventional

This study is to evaluate the safety and effectiveness for the correction of aging mid-face of treatment group compared with the active control group.

NCT ID: NCT04599335 Completed - Lidocaine Clinical Trials

The Evaluation of the Safety and Effectiveness of a Novel Gel-type Sodium Hyaluronate for the Correction of Aging Mid-face

Start date: April 6, 2021
Phase: N/A
Study type: Interventional

This study is to evaluate the safety and effectiveness for the correction of aging mid-face of treatment group compared with the negative control group.

NCT ID: NCT04569045 Completed - Lidocaine Clinical Trials

Evaluate the Safety and Effectiveness of Sodium Hyaluronate When Used for the Correction of Nasolabial Folds

Start date: August 20, 2020
Phase: N/A
Study type: Interventional

The aim of this study is to evaluate the safety and effectiveness of pain relief of modified sodium hyaluronate gel for injection when used for the correction of moderate or severe nasolabial folds.

NCT ID: NCT04546516 Completed - Dermal Filler Clinical Trials

Safety and Efficacy of the HA-based Dermal Fillers HYAcorp Lips and Face

PMCF_HYAcorp
Start date: September 8, 2020
Phase:
Study type: Observational

Purpose of this study is the demonstration of safety and efficacy of the dermal fillers HYAcorp Lips and HYAcorp Face for restoration of the facial volume and contour.

NCT ID: NCT04546152 Completed - Dermal Filler Clinical Trials

Safety and Efficacy of the HA-based Dermal Fillers HYAPROF® SOFT and HYAPROF® BALANCE

PMCF_HYAPROF
Start date: September 16, 2020
Phase:
Study type: Observational

Purpose of this study is the demonstration of safety and efficacy of the dermal fillers HYAPROF® SOFT and HYAPROF® BALANCE for restoration of the facial volume and contour.

NCT ID: NCT02654522 Completed - Dermal Filler Clinical Trials

The Use of a Recombinant DNA-based Hyaluronidase to Dissolve Fixed Amounts of Hyaluronic Acid Dermal Fillers

Start date: January 2016
Phase: Phase 1
Study type: Interventional

The purpose of this study is to determine whether or not Recombinant DNA-based hyaluronidase (RDNAH/Hylenex recombinant), is safe and effective for dissolving hyaluronic acid (HA) dermal fillers.